Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Diagnostic Study to Determine the Prevalence of EGFR Mutations in Asian and Russian Patients With Advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma Histologies

NCT01788163 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01788163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01788163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Diagnostic Study to Determine the Prevalence of EGFR Mutations in Asian and Russian Patients With Advanced NSCLC of Adenocarcinoma and Non-adenocarcinoma Histologies
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Completed
Start date
February 27, 2013
Completion date
June 20, 2016
Enrollment
3,500 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

egfr mutation status in ansclc patients